This topic contains a solution. Click here to go to the answer

Author Question: In 2010, how many people fell below the poverty in the United States? a. About 4.5 or 13 million ... (Read 62 times)

waynest

  • Hero Member
  • *****
  • Posts: 553
In 2010, how many people fell below the poverty in the United States?
 
  a. About 4.5 or 13 million people
  b. About 8.5 or 25 million people
  c. About 15.1 or 46 million people
  d. Fewer people than in the year 2008

Question 2

What is the relationship between race and ethnicity and health status?
 
  a. Ethnic and racial minorities are equally as vulnerable to poor health status as the rest of the population.
  b. Ethnic and racial minorities are less vulnerable to poor health status than the rest of the population.
  c. Ethnic and racial minorities are more vulnerable to poor health status than the rest of the population.
  d. There is no significant relationship between ethnic and racial background and health status.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

juiceman1987

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

ANS: C

Answer to Question 2

ANS: C





 

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library